The Moredun Foundation, the governing body of Moredun Research Institute, was delighted to award two honorary fellowships to David Danson and David Smith at its AGM held on Thursday 3rd of September in recognition of their outstanding contributions to the Moredun Group.
David Danson graduated from Liverpool Veterinary School in 1969 and after a short time in general practice has spent most of his career in industry. He was Director of Global Marketing for Mallinckrodt Animal Health Inc in Chicago, Managing Director, then Chairman of Biokema SA in Lausanne and between 1998 and 2005 was Group Chief Executive of UA Group plc. He served as a non-executive director of Quality Meat Scotland for 3 years where he chaired both the Audit and Remuneration Committees and was a member of the Scottish Executive’s Agriculture Strategy Group. He is currently a Non-Executive Director of Eco Animal Health Group plc, a member of the Council of the Royal Veterinary College and Chairman of RVC Developments Ltd. He joined the board of Moredun Scientific in 2000 and stayed until 2019 and made a significant contribution to help grow the business and success of the company.
Dr. David Smith graduated from the University of Glasgow with a veterinary degree in 1971 and joined Moredun later that year to study for a PhD on immunity to a respiratory virus which infects sheep. In 1975 David turned his attention to studying how sheep become immune to worm infections. More recently he has been successful in the development of a vaccine for Haemonchus contortus, globally the most important worm affecting sheep and goats worldwide. The development of a commercial vaccine against worm infections is a significant breakthrough as the mainstay method to control worm infections in livestock is through drug treatments and there is a growing problem with increasing levels of drug resistance across the world. Dr. Smith is a Director of Wormvax Australia, the commercial company set up to produce and distribute the vaccine in Australia. The vaccine is now sold in Australia and South Africa, with work ongoing to expand markets to South America, Canada and New Zealand
At the AGM Ian Duncan Millar, Chairman of the Moredun Foundation said,
“It is a huge honour to be able to recognise the contribution of people who really have made a difference. This year’s recipients have done just that in very different ways. David Danson by being a board member of Moredun Scientific during a period of considerable growth in business and reputation, achieved in no small part by David’s contribution through his international knowledge, experience and sharp wit. In a very different way David Smith has dedicated his life to the understanding of sheep gut worms, and his achievement in producing and marketing the first vaccine against one of these parasites is truly worthy of recognition, and a wonderful example of the excellence of our Moredun science and scientists”.
For further information, please contact:
Moredun Communications Director